CTC (Chicago Trading Company)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2
Closed -$215K 142
2025
Q4
$215K Sell
2
-1
-33% -$956 ﹤0.01% 154
2025
Q3
$229K Sell
3
-4,397
-100% -$3.27M ﹤0.01% 162
2025
Q2
$3.43M Sell
4,400
-11,300
-72% -$8.78M ﹤0.01% 121
2025
Q1
$13M Sell
15,700
-4,700
-23% -$3.91M 0.01% 99
2024
Q4
$15.7M Buy
20,400
+20,114
+7,033% +$16.7M 0.01% 114
2024
Q3
$25.3M Sell
286
-489
-63% -$440K 0.01% 103
2024
Q2
$70.2M Buy
775
+353
+84% +$282K 0.04% 76
2024
Q1
$32.8M Buy
+422
New +$300K 0.02% 142

Other funds holding LLY

CTC (Chicago Trading Company)'s LLY Position: Q4 2025 in Review

CTC (Chicago Trading Company) sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 461 shares — an estimated $441K sold.

CTC (Chicago Trading Company) first reported a position in LLY in Q1 2024 and held it in 6 quarters. The position peaked at $13.6M in Q2 2024. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • CTC (Chicago Trading Company) reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • CTC (Chicago Trading Company) sold 461 Eli Lilly shares in Q4 2025, an estimated $441K.
  • CTC (Chicago Trading Company) first reported a position in Eli Lilly in Q1 2024 and held it in 6 quarters.
  • CTC (Chicago Trading Company)'s Eli Lilly position peaked at $13.6M in Q2 2024.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on CTC (Chicago Trading Company)'s 13F filing for Q4 2025, filed 18 Feb 2026.